Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment

被引:126
|
作者
Palepu, A
Horton, NJ
Tibbetts, N
Meli, S
Samet, JH
机构
[1] Univ British Columbia, St Pauls Hosp, Dept Med, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V5Z 1M9, Canada
[2] DM STAT Inc, Medford, MA USA
[3] Boston Univ, Sch Med, Northampton, MA USA
[4] Boston Univ, Sch Publ Hlth, Northampton, MA USA
[5] Smith Coll, Dept Math, Northampton, MA 01063 USA
[6] Boston Univ, Dept Med, Gen Internal Med Sect, CARE Unit, Vancouver, WA USA
[7] Boston Univ, Dept Social & Behav Sci, Vancouver, WA USA
关键词
access; adherence; alcohol; antiretroviral therapy; HIV; substance abuse treatment; substance use;
D O I
10.1111/j.1360-0443.2003.00670.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aim We examined the association of substance abuse treatment with uptake, adherence and virological response to highly active antiretroviral therapy (HAART) among HIV-infected people with a history of alcohol problems. Design Prospective cohort study. Methods A standardized questionnaire was administered to 349 HIV-infected participants with a history of alcohol problems regarding demographics, substance use, use of substance abuse treatment and uptake of and adherence to HAART. These subjects were followed every 6 months for up to seven occasions. We defined substance abuse treatment services as any of the following in the past 6 months: 12 weeks in a half-way house or residential facility; 12 visits to a substance abuse counselor or mental health professional; or participation in any methadone maintenance program. Our outcome variables were uptake of antiretroviral therapy, 30-day self-reported adherence and HIV viral load suppression. Findings At baseline, 59% (205/349) of subjects were receiving HAART. Engagement in substance abuse treatment was independently associated with receiving antiretroviral therapy (adjusted OR; 95% CI: 1.70; 1.03-2.83). Substance abuse treatment was not associated with 30-day adherence or HIV viral load suppression. More depressive symptoms (0.48; 0.32-0.78) and use of drugs or alcohol in the previous 30 days (0.17; 0.11-0.28) were associated with worse 30-day adherence. HIV viral load suppression was positively associated with higher doses of antiretroviral medication (1.29; 1.15-1.45) and older age (1.04; 1.00-1.07) and negatively associated with use of drugs or alcohol in the previous 30 days (0.51; 0.33-0.78). Conclusion Substance abuse treatment was associated with receipt of HAART; however, it was not associated with adherence or HIV viral load suppression. Substance abuse treatment programs may provide an opportunity for HIV-infected people with alcohol or drug problems to openly address issues of HIV care including enhancing adherence to HAART.
引用
收藏
页码:361 / 368
页数:8
相关论文
共 50 条
  • [21] Contribution of Substance Use Disorders on HIV Treatment Outcomes and Antiretroviral Medication Adherence Among HIV-Infected Persons Entering Jail
    Chitsaz, Ehsan
    Meyer, Jaimie P.
    Krishnan, Archana
    Springer, Sandra A.
    Marcus, Ruthanne
    Zaller, Nick
    Jordan, Alison O.
    Lincoln, Thomas
    Flanigan, Timothy P.
    Porterfield, Jeff
    Altice, Frederick L.
    AIDS AND BEHAVIOR, 2013, 17 : 118 - 127
  • [22] Contribution of Substance Use Disorders on HIV Treatment Outcomes and Antiretroviral Medication Adherence Among HIV-Infected Persons Entering Jail
    Ehsan Chitsaz
    Jaimie P. Meyer
    Archana Krishnan
    Sandra A. Springer
    Ruthanne Marcus
    Nick Zaller
    Alison O. Jordan
    Thomas Lincoln
    Timothy P. Flanigan
    Jeff Porterfield
    Frederick L. Altice
    AIDS and Behavior, 2013, 17 : 118 - 127
  • [23] Feasibility and Acceptability of a Smartphone App for Daily Reports of Substance Use and Antiretroviral Therapy Adherence among HIV-Infected Adults
    Przybyla, Sarahmona M.
    Eliseo-Arras, Rebecca K.
    Krawiec, Gabriela
    Gower, Emily
    Dermen, Kurt
    AIDS RESEARCH AND TREATMENT, 2016, 2016
  • [24] The Impact of Neuropsychological Functioning on Adherence to HAART in HIV-Infected Substance Abuse Patients
    Applebaum, Allison J.
    Reilly, Laura C.
    Gonzalez, Jeffrey S.
    Richardson, Mark A.
    Leveroni, Catherine L.
    Safren, Steven A.
    AIDS PATIENT CARE AND STDS, 2009, 23 (06) : 455 - 462
  • [25] Legal problems and substance use among HIV-infected patients
    Parro Torres, C.
    Hernandez Huerta, D.
    Ochoa Mangado, E.
    Madoz Gurpide, A.
    Moreno Zamora, A. M.
    EUROPEAN PSYCHIATRY, 2016, 33 : S180 - S180
  • [26] Adherence to Highly Active Antiretroviral Treatment in HIV-Infected Rwandan Women
    Musiime, Stephenson
    Muhairwe, Fred
    Rutagengwa, Alfred
    Mutimura, Eugene
    Anastos, Kathryn
    Hoover, Donald R.
    Shi Qiuhu
    Munyazesa, Elizaphane
    Emile, Ivan
    Uwineza, Annette
    Cowan, Ethan
    PLOS ONE, 2011, 6 (11):
  • [27] Adherence to highly active antiretroviral therapy in substance abusers with HIV/AIDS.
    Ng, JJ
    Rosen, RK
    Malcolm, SE
    Stein, MD
    Stone, VE
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2000, 15 : 165 - 165
  • [28] The Role of Substance Use and Mental Health Problems in Medication Adherence Among HIV-Infected MSM
    White, Jaclyn M.
    Gordon, Janna R.
    Mimiaga, Matthew J.
    LGBT HEALTH, 2014, 1 (04) : 319 - 322
  • [29] ACTIVE SUBSTANCE USE AND SATISFACTION WITH RELATIONSHIPS, SOCIAL SUPPORT AMONG HIV-INFECTED MINORITY WOMEN IN SUBSTANCE USE TREATMENT
    Barinas, Jennifer
    Bedoya, Andres
    Psaros, Christina
    Safren, Steven A.
    ANNALS OF BEHAVIORAL MEDICINE, 2011, 41 : S19 - S19
  • [30] Use of highly active antiretroviral therapy in HIV-infected women: Impact of HIV specialist care
    Gardner, LI
    Holmberg, SD
    Moore, J
    Arnsten, JH
    Mayer, KH
    Rompalo, A
    Schuman, P
    Smith, DK
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (01) : 69 - 75